Ligand · U35
U35 · (2~{S})-3-methyl-2-[pentanoyl-[[4-[2-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
U35, (2~{S})-3-methyl-2-[pentanoyl-[[4-[2-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid (C24 H29 N5 O3, 435.5 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (3 PDB entries). Every binding site…
- Component
- U35
- Formula
- C24 H29 N5 O3
- Class
- ligand
- Structures
- 4
- PDB entries
- 3
Binding sites
U35 in 4 structures; the first of them:
- 7BM1 · Notum_Valsartan complex · U35 A514 · binds TRP128, TYR129, VAL187, ALA233, THR236, PHE268, LEU269, PRO287 and 6 more
- 8DQT · Human PDK1 kinase domain in complex with Valsartan · U35 A401 · binds VAL124, THR128, GLN150, LEU155
- 8EGU · Branched chain ketoacid dehydrogenase kinase complexes · U35 A402 · binds LEU68, ILE72, LEU98, TYR99, ALA102, LEU106, VAL125, LEU128 and 11 more
- 7BM1 · NOTUM_VALSARTAN complex · U35 A514 · binds TRP128, TYR129, VAL187, ALA233, THR236, PHE268, LEU269, PRO287 and 6 more
Residues it binds most
LEU 7, VAL 6, THR 6, ILE 5, ARG 3, PHE 3, TYR 5, ALA 3, PRO 5, GLY 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.